Clinical trial

USG PECS vs LIA for Breast Cancer Surgery

NCT03555227

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-09-25

PhaseNA

Study timeline

Study start (actual)2017-09-25Date precision: day

Registry last updated2018-11-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Femaleunresolved

Interventions

USG PECS2 with Drug A (active)PROCEDURE

USG PECS2 with Drug P (placebo)PROCEDURE

Wound infiltration with Drug P (placebo)PROCEDURE

Wound infiltration with Drug A (active)PROCEDURE

Sponsors & collaborators

National Health Service, United Kingdomlead sponsor

Southern Health and Social Care Trustcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03555227 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.